IP Library Granted Patent US 8,377,110
Granted Patent B2
US 8,377,110 · App. 10/820,455 · Granted Feb 19, 2013

Endolumenal vascular prosthesis with neointima inhibiting polymeric sleeve

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,377,110
App. No.
10/820,455
Granted
Feb 19, 2013
Kind
B2
Abstract

The present invention is related to a low profile endolumenal prosthesis. The prosthesis comprises a radially expandable tubular wire support and an expanded PTFE membrane. The density, wall thickness and intranodal distance of the ePTFE are selected to inhibit the formation and nourishment of a viable neointima on the inner surface of the prosthesis, through the ePTFE membrane.

Claims (50)

1. An endolumenal prosthesis having a lumenal surface and an ablumenal surface, comprising:

a tubular wire support with proximal and distal ends and a central lumen extending therebetween, the wire support comprising at least two axially adjacent tubular segments, each segment comprising a series of proximal and distal bends connected by a length of wire, wherein the wire support is radially compressible into a first, reduced cross sectional configuration for translumenal navigation to a treatment site in a body lumen and self expandable to a second, enlarged cross sectional configuration for deployment at the treatment site in the body lumen; and

a uniform porous tubular ePTFE sheath on the wire support, the tubular sheath having a sheath proximal end region and a sheath distal end region, wherein the sheath is porous and configured to inhibit sufficient cellular ingrowth through the wall of the sheath that would permit the formation of a viable neointimal layer on the lumenal surface of the sheath at the sheath proximal and distal end regions without a coating on the sheath that would inhibit cellular ingrowth,

wherein the sheath is formed from a single ply of ePTFE and wherein a wall thickness of the sheath is the thickness of the single ply of ePTFE.

2. The endolumenal prosthesis of claim 1 , wherein the ePTFE sheath wall thickness is no greater than about 0.2 mm.

3. The endolumenal prosthesis of claim 2 , wherein the ePTFE sheath wall thickness is about 0.1 mm.

4. The endolumenal prosthesis of claim 2 , comprising at least three segments.

5. The endolumenal prosthesis of claim 2 , comprising at least five segments.

6. The endolumenal prosthesis of claim 2 , wherein each segment comprises from about 4 proximal bends to about 12 proximal bends.

7. The endolumenal prosthesis of claim 2 , wherein at least the first and second axially adjacent tubular segments are joined by at least one folded link extending therebetween.

8. The endolumenal prosthesis of claim 7 , wherein the first tubular segment includes two side-by-side legs with a first apex thereon and the folded link is formed by folding around the first apex around a second apex formed on the second tubular segment.

9. The endolumenal prosthesis of claim 1 , wherein the ePTFE sheath wall thickness is within the range of from about 0.05 mm to about 0.15 mm.

10. The endolumenal prosthesis of claim 9 , wherein the ePTFE sheath has a density within the range of from about 1.1 to about 1.5 grams per milliliter.

11. The endolumenal prosthesis of claim 9 , wherein the ePTFE sheath has a plurality of nodes, and the average distance between nodes is within the range of from about 6 microns to about 80 microns.

12. The endolumenal prosthesis of claim 9 , wherein the ePTFE sheath has a density of at least about 0.75 grams per milliliter.

13. The endolumenal prosthesis of claim 12 , wherein the ePTFE sheath has a plurality of nodes, and the average distance between nodes is within the range of from about 6 microns to about 80 microns.

14. The endolumenal prosthesis of claim 1 , wherein the ePTFE sheath has a density of at least about 0.5 grams per milliliter.

15. The endolumenal prosthesis of claim 1 , wherein the ePTFE sheath has a plurality of nodes, and the average distance between nodes is within the range of from about 6 microns to about 80 microns.

16. The endolumenal prosthesis of claim 1 , wherein the ePTFE sheath has a water entry pressure in the range of from about 10 psi to about 24 psi.

17. A bifurcated endolumenal prosthesis having a lumenal surface and an ablumenal surface, comprising:

a proximal wire support section having a proximal end, a distal end and a central lumen extending therethrough, the proximal support section comprising at least two axially adjacent tubular segments comprising a series of distal and proximal bends connected by struts;

a first wire branch section at the distal end of the proximal support;

a second wire branch section at the distal end of the proximal support; and

a uniform porous membrane carried by the wire support section, the membrane having a membrane proximal end region and membrane distal end regions and configured to inhibit cellular growth through the membrane that would be sufficient to enable the formation of a thin, viable neointimal layer on the lumenal surface of the membrane at least at the membrane proximal and distal end regions without a coating on the membrane that would inhibit cellular ingrowth, the membrane consists of and has a thickness of a single ply of ePTFE.

18. A prosthetic vascular graft, comprising:

an expandable tubular wire support;

a uniform porous, tubular ePTFE layer carried by the support, the ePTFE layer formed from a single ply of ePTFE and having:

a wall thickness equal to a thickness of the single ply of ePTFE and less than about 0.15 millimeters;

an average density of greater than about 0.75 grams per milliliter; and

an average distance between nodes in the range of between about 6 to about 80 microns;

so that the uniform porous ePTFE layer prevents the formation and nourishment of a viable neointimal layer therethrough along portions of the tubular ePTFE layer's axial length, which are in contact with a vessel wall.

19. An artificial vascular prosthesis comprising an enlargeable support structure having an expanded, uniform porous, polytetrafluoroethylene layer thereon, the layer consisting of a single ply of polytetrafluoroethylene and having a wall thickness equal to the thickness of the single ply of polytetrafluoroethylene and a microstructure consisting of nodes interconnected by fibrils which prevents tissue ingrowth through portions of the layer that contact a vessel wall when the prosthesis is implanted to span an aneurysm, in which either the density is greater than about 1 gram per milliliter or the wall thickness is less than about 0.2 millimeters, or both.

20. A method of treating a patient, comprising:

providing an implantable tubular prosthesis, having a uniform porous ePTFE layer formed from a single ply of ePTFE thereon, the porous ePTFE layer having a wall thickness equal to the thickness of the single ply of ePTFE, a proximal end and a distal end;

positioning the prosthesis across a defect in a vessel such that a contacting portion of a first side of the layer is in contact with the wall of the vessel; thereby inhibiting formation of a viable neointima on a second side of the layer throughout the contacting portion, nourished through the layer;

wherein said inhibiting step is a result of the ePTFE layer having a density of greater than about 0.75 grams per milliliter and a wall thickness of less than 0.2 mm.

21. An endolumenal prosthesis having a lumenal surface and an ablumenal surface, comprising:

a tubular wire support with proximal and distal ends and a central lumen extending therebetween, the wire support comprising at least two axially adjacent tubular segments, each segment comprising a series of proximal and distal bends wherein the wire support is radially compressible into a first, reduced cross sectional configuration for translumenal navigation to a treatment site in a body lumen and self expandable to a second, enlarged cross sectional configuration for deployment at the treatment site in the body lumen; and

a uniform porous, tubular ePTFE sheath on the wire support, the porous, tubular sheath being formed from a single ply of ePTFE and having a wall thickness equal to the thickness of the single ply of ePTFE, the tubular sheath having a proximal end and a distal end and being configured to have a water entry pressure of at least about 10 psi, and wherein the uniform porous tubular sheath is configured to inhibit the formation of a viable neointimal layer on the lumenal surface of the without a coating on the sheath that would inhibit cellular ingrowth.

22. The endolumenal prosthesis of claim 21 , wherein the ePTFE sheath wall thickness is no greater than about 0.2 mm.

23. The endolumenal prosthesis of claim 22 , wherein the ePTFE sheath wall thickness is about 0.1 mm.

24. The endolumenal prosthesis of claim 21 , wherein the ePTFE sheath wall thickness is within the range of from about 0.05 mm to about 0.15 mm.

25. The endolumenal prosthesis of claim 24 , wherein the ePTFE sheath has a density within the range of from about 1.1 to about 1.5 grams per milliliter.

26. The endolumenal prosthesis of claim 24 , wherein the ePTFE sheath has a plurality of nodes, and the average distance between nodes is within the range of from about 6 microns to about 80 microns.

27. The endolumenal prosthesis of claim 24 , wherein the ePTFE sheath has a density of at least about 0.75 grams per milliliter.

28. The endolumenal prosthesis of claim 27 , wherein the ePTFE sheath has a plurality of nodes, and the average distance between nodes is within the range of from about 6 microns to about 80 microns.

29. The endolumenal prosthesis of claim 21 , wherein the ePTFE sheath has a density of at least about 0.5 grams per milliliter.

30. The endolumenal prosthesis of claim 21 , wherein the ePTFE sheath has a plurality of nodes, and the average distance between nodes is within the range of from about 6 microns to about 80 microns.

31. The endolumenal prosthesis of claim 21 , wherein the tubular sheath is further configured to inhibit the formation of a viable neointimal layer on the lumenal surface of the sheath at the distal end.

32. The endolumenal prosthesis of claim 21 , wherein the proximal end comprises a single opening and the distal end comprises two openings, such that the prosthesis is configured for implantation at a vascular bifurcation.

Assignments (9)
SECURITY INTEREST Recorded Apr 1, 2021
From: ENDOLOGIX LLC
To: SILICON VALLEY BANK
Reel/Frame 055794/0911 →
CHANGE OF NAME Recorded Oct 2, 2020
From: ENDOLOGIX, INC.
To: ENDOLOGIX LLC
Reel/Frame 053971/0135 →
SECURITY INTEREST Recorded Oct 2, 2020
From: ENDOLOGIX LLC (F/K/A ENDOLOGIX, INC.); NELLIX, INC.; TRIVASCULAR TECHNOLOGIES, INC.; TRIVASCULAR, INC.; TRIVASCULAR CANADA, LLC
To: DEERFIELD PRIVATE DESIGN FUND IV, L.P.
Reel/Frame 053971/0052 →
SECURITY INTEREST Recorded Feb 26, 2020
From: ENDOLOGIX, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 052918/0530 →
SECURITY INTEREST Recorded Aug 10, 2018
From: ENDOLOGIX, INC.; NELLIX, INC.; TRIVASCULAR, INC.
To: DEERFIELD ELGX REVOLVER, LLC, AS AGENT
Reel/Frame 046762/0169 →
RELEASE OF SECURITY INTEREST Recorded Jan 12, 2018
From: DEERFIELD ELGX REVOLVER, LLC, AS AGENT
To: ENDOLOGIX, INC.; NELLIX, INC.; TRIVASCULAR, INC.
Reel/Frame 045059/0971 →
SECURITY INTEREST Recorded Apr 3, 2017
From: ENDOLOGIX, INC.; NELLIX, INC.; TRIVASCULAR, INC.
To: DEERFIELD ELGX REVOLVER, LLC, AS AGENT
Reel/Frame 042146/0454 →
SECURITY INTEREST Recorded Apr 3, 2017
From: ENDOLOGIX, INC.; NELLIX, INC.; TRIVASCULAR, INC.
To: DEERFIELD PRIVATE DESIGN FUND IV, L.P., AS AGENT
Reel/Frame 042141/0354 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 27, 2004
From: DOUGLAS, MYLES S.; ZENG, FRANK M.; GRAY, BRIAN C.
To: ENDOLOGIX, INC.
Reel/Frame 015818/0138 →